ORAMED PHARMACEUTICALS INC. ORMP Income Statement

Oramed pharmaceuticals inc. (ORMP)

Income statement / Quarterly

Feb'20	Nov'19	Aug'19	May'19	Feb'19	Nov'18	Aug'18	May'18	Feb'18	Nov'17	Aug'17	May'17	Feb'17	Nov'16	Aug'16	May'16	Feb'16	Nov'15	Aug'15	May'15	Feb'15	Nov'14	Aug'14	May'14	Feb'14	Nov'13	Aug'13	May'13	Feb'13	Nov'12	Aug'12	May'12	Feb'12	Nov'11	Aug'11	May'11	Feb'11	Nov'10
REVENUES
674	674	681	682	666	674	617	617	604	611	618	617	611	610	679	-163	125	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
COST OF REVENUES
-	-	0	0	55	35	-	-86	-	-	0	0	0	187	-	-8	4	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
RESEARCH AND DEVELOPMENT EXPENSES
3,320	2,022	2,200	3,861	3,114	4,347	2,734	4,194	2,724	2,327	2,536	2,267	3,125	2,353	10,017	-1,710	1,303	-1,901	1,428	915	1,136	1,302	2,942	-1,089	674	750	-4,249	835	748	392	536	249	710	184	290	241	341	286
IMPAIRMENT OF INVESTMENT
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	0	0	0	0	0	0
GENERAL AND ADMINISTRATIVE EXPENSES
1,391	1,081	826	899	1,065	932	1,033	1,043	991	1,016	935	505	851	468	2,825	-555	730	-548	745	719	538	600	2,513	-814	512	418	-3,381	499	510	339	400	290	229	281	304	350	305	315
OPERATING LOSS
-4,037	-2,429	-2,345	-4,078	-3,568	-4,640	-3,150	-4,534	-3,111	-2,732	-2,853	-2,155	-3,365	-2,398	-12,657	2,110	-1,912	2,449	-2,173	-1,634	-1,674	-1,902	-5,455	1,903	-1,186	-1,168	7,630	-1,334	-1,259	-731	-937	-540	-940	-465	-594	-591	-647	-601
FINANCIAL INCOME
169	209	239	263	273	286	255	209	217	222	193	210	203	186	407	-137	128	76	52	51	38	27	184	-79	74	46	-403	84	66	72	-1	0	7	6	0	22	7	2
GAIN ON SALE OF INVESTMENT
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	0	0	0	1,033	0	0
IMPAIRMENT OF AVAILABLE- FOR-SALE SECURITIES
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	140	0	43	0	197	0	0	0
FINANCIAL EXPENSES
2	20	444	14	19	8	31	29	22	21	36	20	21	24	65	-23	34	17	-4	0	1	21	10	-4	3	2	-651	6	32	299	159	10	9	19	5	6	3	3
LOSS (GAIN) FROM CHANGES IN FAIR VALUE OF INVESTMENT
182	-303	-	-243	-87	60	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
LOSS BEFORE TAXES ON INCOME
3,688	-	-	-	3,401	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
LOSS BEFORE TAXES ON INCOME
-	-	-	-4,072	-	-	-	-4,354	-2,916	-	-2,696	-1,965	-3,183	-2,236	-12,197	1,996	-1,818	2,390	-	-	-	-	-	-	-	-	-	-	-1,225	-958	-1,239	-550	-985	-478	-797	457	-642	-602
TAXES ON INCOME
-	-	-	-	-300	-	-	-	-	-	0	0	0	400	1,335	0	0	0	-	-	-	-	-	-	-	-	-	-	0	0	90	0	0	0	-23	0	0	0
NET LOSS FOR THE PERIOD
3,688	-2,543	-9,682	-4,072	3,701	-4,302	-2,926	-4,354	-2,916	-2,531	-2,696	-1,965	-3,183	-2,636	-8,752	1,996	-1,818	-2,390	-2,116	-1,583	-1,637	-1,896	-5,285	1,828	-1,115	-1,124	7,672	-1,256	-1,225	-958	-1,329	-550	-985	-478	-773	457	-642	-602
SUBSEQUENT INCREASE IN THE FAIR VALUE OF AVAILABLE FOR SALE SECURITIES PREVIOUSLY WRITTEN DOWN AS IMPAIRED
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	20	49	5	-215	-38	5	117	-	-15	-4	-	-	-	-	-
RECLASSIFICATION ADJUSTMENT FOR GAINS INCLUDED IN NET LOSS
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	72	-36	26	18	-159	18	50	0	-	0	-	-	-	-	-	-
RECLASSIFICATION ADJUSTMENT FOR GAINS INCLUDED IN NET LOSS
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-
UNREALIZED INCOME ON AVAILABLE FOR SALE SECURITIES
-	-	-	-	-	-	504	-115	-414	326	-96	286	168	-63	-852	-84	78	406	395	63	7	-359	-629	323	490	44	-380	-55	53	118	-	0	0	-	-	-	-	-
TOTAL OTHER COMPREHENSIVE INCOME
-	-	-	-	-	-	504	-115	-414	326	-96	286	168	-63	-852	-84	78	406	395	63	7	-359	-775	379	513	31	-435	-112	8	235	-	-15	-4	-	-	-	-	-
SUBSEQUENT INCREASE IN THE FAIR VALUE OF AVAILABLE FOR SALE SECURITIES PREVIOUSLY WRITTEN DOWN AS IMPAIRED
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-4	-	-	-	-
UNREALIZED GAIN ON AVAILABLE FOR SALE SECURITIES
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
TOTAL OTHER COMPREHENSIVE INCOME
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4	-	-	-	-
TOTAL COMPREHENSIVE LOSS FOR THE PERIOD
-	-	-	-4,072	-	-	-2,422	-4,469	-3,330	-2,205	-2,792	-1,679	-3,015	-2,699	-14,384	1,912	-1,740	2,796	-1,721	-1,520	-1,630	-2,255	-6,060	2,207	-602	-1,093	7,237	-1,368	-1,217	-722	-1,313	-566	-989	-474	-	-	-	-
LOSS PER SHARE OF COMMON STOCK:
BASIC AND DILUTED LOSS PER SHARE OF COMMON STOCK
0.21	0.15	0.13	0.23	0.21	0.25	0.18	0.30	0.20	0.18	0.20	0.15	0.24	0.20	0.37	0.15	0.14	0.21	0.18	0.15	0.15	0.19	0.18	0.18	0.12	0.14	0.45	0.17	-0.17	0.14	0.30	0.09	0.17	0.01	-0.03	-0.01	0.01	0.01
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING BASIC AND DILUTED LOSS PER SHARE OF COMMON STOCK
17,818	17,472	17,458	17,456	17,454	17,448	16,325	14,518	14,445	14,239	13,450	13,300	13,279	13,205	13,153	13,118	12,652	11,572	11,485	10,827	10,826	10,142	10,019	9,888	9,127	7,941	7,572	7,223	7,212	6,828	-	5,860	5,848	-	-	-	-	-
WEIGHTED AVERAGE NUMBER OF BASIC AND DILUTED SHARES USED IN COMPUTATION OF LOSS PER SHARE:
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	70,104	-	-	-	-
WEIGHTED AVERAGE NUMBER OF SHARES USED IN COMPUTATION OF LOSS (INCOME) PER SHARE: Basic
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	69,049	-	-
WEIGHTED AVERAGE NUMBER OF SHARES USED IN COMPUTATION OF LOSS (INCOME) PER SHARE: Diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	72,410	-	-
WEIGHTED AVERAGE NUMBER OF COMMON STOCK USED IN COMPUTING BASIC AND DILUTED LOSS PER COMMON STOCK
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	62,804	57,932